BPG is committed to discovery and dissemination of knowledge
Review
Copyright ©The Author(s) 2025.
World J Hepatol. Sep 27, 2025; 17(9): 107705
Published online Sep 27, 2025. doi: 10.4254/wjh.v17.i9.107705
Table 1 Classification, genetic basis, and clinical features of major porphyria subtypes
Porphyria type
Enzyme deficiency
Gene
Inheritance
Primary site of synthesis
Accumulated porphyrin intermediate
Neurovisceral symptoms
Cutaneous symptoms
Liver involvement
Acute hepatic porphyrias
ADPALA-dehydrataseALADARLiverALA+-/+-
AIPPBG deaminaseHMBSADLiverALA, PBG++--
HCPCoproporphyrinogen oxidaseCOPROXADLiverALA, PBG, coproporphyrin III++-
VPProtoporphyrinogen oxidasePROTOXADLiverALA, PBG, coproporphyrin III, protoporphyrin IX+++
Hepatic cutaneous porphyrias
PCTUroporphyrinogen decarboxylaseURODAD/sporadicLiverUrinary porphyrins, carboxylated porphyrin -+++
HEPUroporphyrinogen decarboxylaseURODARLiverUrinary porphyrins, carboxylated porphyrin-+++
Erythropoietic cutaneous porphyrias
CEPUroporphyrinogen III synthaseUROSARBone marrowUrinary porphyrin 1, fecal porphyrin I-++-
EPPFerrochelataseFECHARBone marrowProtoporphyrin IX-+++
XLPALA synthase 2ALAS2X-linkedBone marrowProtoporphyrin IX, Zn-bound protoporphyrin IX-/+++
Table 2 Categorization of high-risk pharmacological agents in porphyria
Drug category
Drug name
Psychiatric drugsPhenobarbital, Phenytoin, Chlorzoxazone, Diphenhydramine, Carbamazepine, Sodium Valproate, Oxcarbazepine, Ergometrine, Methyldopa, Flurazepam
Intravenous anestheticsThiopental sodium
Antimicrobial drugsVoriconazole, Itraconazole, Fluconazole, Trimethoprim, Chloramphenicol, Erythromycin, Sulfasalazine, Sulfamethoxazole, Rifampicin, Rifapentine, Ritonavir, Nevirapine, Dapsone, Furantoin
Hormonal drugsNandrolone, Estrogen drugs, Oral contraceptives, Mifepristone, Danazol
Other drugsSpironolactone, Praziquantel, Hydralazine